Claire Francoz

TL;DR: In this article, the authors evaluated a therapeutic strategy uniformly applied during the last 8 years in a single referral center, and concluded that excellent survival can be achieved in BCS patients when therapeutic procedures are introduced by order of increasing invasiveness, based on the response to previous therapy rather than on the severity of the patient's condition.

TL;DR: Acute decompensation without ACLF is a heterogeneous condition with three different clinical courses and two major pathophysiological mechanisms: systemic inflammation and portal hypertension.

TL;DR: There is no evidence that pre-transplant portal vein thrombosis justifies long term anticoagulation post-trans transplantation, provided portal flow has been restored through conventional end-to-end portal anastomosis.

TL;DR: This study identified precipitants that are significantly associated with a distinct clinical course and prognosis of patients with AD and specific preventive and therapeutic strategies targeting these events may improve outcome in decompensated cirrhosis.

TL;DR: Survival of patients with PoPH is strongly associated with the severity of liver disease, and patients who underwent liver transplantation had the best long-term outcomes.